ABCA1 and diabetic kidney disease: In support, SOAT1 inhibitor treatment protected podocytes from DKD sera-induced cytotoxicity in vitro and db/db mice from renal injury in vivo through a mechanism dependent on ABCA1-mediated cholesterol efflux.